Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NCT02984566 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT02984566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02984566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
Lead sponsor
University of Sydney
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 14, 2020
Completion date
July 31, 2026
Enrollment
32 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer